Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

✍ Scribed by Guilhot, F.; Apperley, J.; Kim, D.-W.; Bullorsky, E. O.; Baccarani, M.; Roboz, G. J.; Amadori, S.; de Souza, C. A.; Lipton, J. H.; Hochhaus, A.; Heim, D.; Larson, R. A.; Branford, S.; Muller, M. C.; Agarwal, P.; Gollerkeri, A.; Talpaz, M.

• Book ID: 124057190
• Publisher: American Society of Hematology
• Year: 2007
• Tongue: English
• Weight: 137 KB
• Volume: 109
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2006-09-046839